Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


Oxford Investment Opportunity Network launches Medical Healthcare Group


Oxford Investment Opportunity Network (OION), Europe’s leading technology business angel investment network, has launched a new Medical Devices and Healthcare Technologies Group, known as OION MedTech, to assist companies in the healthcare sector seeking business development funding.

A launch event, held in the Sophos building at Abingdon, Oxfordshire, attracted around 100 investors and guests. They enjoyed presentations by an expert panel of healthcare industry representatives and financiers before discussing the role that private equity can play in helping entrepreneurs to develop innovative technologies. The audience then viewed investment pitches by six innovative companies seeking funding to exploit healthcare technologies.

The expert panel was chaired by Dr Andrew Mackintosh, former Chief Executive of Oxford Instruments plc, and members included Nick Dunster, Business Analyst at the Wellcome Trust, who spoke about early stage investments in medical technologies, while Margaret Parton, Chief Executive of the NHS National Technology Adoption Hub, explained how companies can plan for market access into the NHS. Edward Rudd, co-founder and Partner at Longbow Capital LLP, a VC firm that works with Boots Centre for Innovation to identify consumer health opportunities, provided an insight into what venture capitalists look for when investing in companies and Paul Weinberger, Director of Clinical Development at Enigma Diagnostics, gave an overview of the in-vitro diagnostics sector.

Eileen Modral, Manager of Oxfordshire Investment Opportunity Network (OION), said: “The medical device and healthcare technologies or medtech sector has become an increasingly important sector of our economy because of the significant public health benefits that can result from the development of these technologies.

“Access to patient capital, such as that provided by business angel investors, is critical to the successful development of innovative healthcare ideas. I am delighted to announce the launch of this sub-brand of OION, known as OION MedTech, to provide a focus for investment in healthcare opportunities. We will be holding OION MedTech meetings every six months and I welcome enquiries from investors with an interest in the healthcare sector and from healthcare companies looking to raise funding of up to £2 million.”

Companies presenting at the first OION MedTech meeting included: Jbol Ltd, an Oxfordshire urology company, which has developed a patented low-contamination device for urine testing that is used by GPs and hospitals and is also biodegradable.

Bioinnovel Ltd, a Cambridge bioprocess engineering company from the Babraham Bio-incubator, is developing a range of ultrasound sensors for process scale-up that can be used in the biopharma industry to accelerate the time it takes for new drugs to come to market.

APA Parafricta Ltd, located in Hampshire, is developing a special fabric that can be used in garments and bedclothes to protect against bedsores - expenditure on pressure sores by the NHS exceeds £2.1 billion every year. Other applications include patient handling.

Sound Foresight Ltd was established to exploit intellectual property from the University of Leeds in the area of ultrasound applied to mobility aids for people with impaired vision. The company has developed the UltraCane™, a cane incorporating ultrasound transmitters that uses bat-like echo location to communicate a map of the surrounding area to the user via vibrating pads on the handle. The UltraCane™ could revolutionise mobility for the vision impaired who until now have been faced with a choice between using a low-tech long white cane or a guide dog.

Domainex Ltd, a spin-out molecular biology company from UCL located in London and Cambridge, has developed a proprietary technology that facilitates the cloning of gene targets for drug discovery. These targets are highly attractive for drug discovery but to date have been v


Publisher Contact Information:

The Oxfordshire Investment Opportunity Network (OION)
+44 (0)1865 811199
m.henry@oxin.co.uk

Company profile of The Oxfordshire Investment Opportunity Network (OION)
Past press releases of The Oxfordshire Investment Opportunity Network (OION).

Data


26,231
Tech investments
From our Online Data Service
16,945
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Oct 11N/AInternet services
Oct 11€1.1MKnowledge management
Oct 11N/AInternet services
Oct 11€13.0MBiotechnology
Oct 11N/AMedical devices
Oct 10€50.0MInternet services
Oct 10€23.0MOther Computers & Electronics

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.